80576 Federal Register / Vol. 89, No. 192 / Thursday, October 3, 2024 / Notices 

pertaining to the continuance and 

improvement of functions within the 

authority of the Department of Health 

and Human Services concerning 

protections for human subjects in 

research. 

SACHRP is authorized to have 11 

public voting members. The members 

are selected from among individuals 

possessing demonstrated experience 

and expertise in any of the several 

disciplines and fields pertinent to 

human subjects protection and/or 

clinical research. The Committee’s 

public members are appointed by the 

Secretary. All public members of the 

Committee are classified as special 

government employees (SGEs). The 

Committee structure includes nonvoting ex-officio representation from 

eight Departmental agencies. 

On September 12, 2024 the Secretary 

approved for the SACHRP charter to be 

renewed. The new charter will be 

effected and filed with the appropriate 

Congressional committees and the 

Library of Congress on or about October 

1, 2024. Renewal of the Committee’s 

charter gives authorization for the 

Committee to continue to operate until 

October 1, 2026. 

A copy of the SACHRP charter is 

available on the Committee’s website at 

https://www.hhs.gov/ohrp/sachrpcommittee/charter/index.html. A copy 

of the charter can also be obtained by 

accessing the FACA database that is 

maintained by the Committee 

Management Secretariat under the 

General Services Administration. The 

website address for the FACA database 

is www.facadatabase.gov. 

Julie Kaneshiro, 

Acting Director, Office for Human Research 

Protections. 

[FR Doc. 2024–22797 Filed 10–2–24; 8:45 am] 

BILLING CODE 4150–36–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Aging; Notice of 

Closed Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel; Aging 

Primate. 

Date: November 18, 2024. 

Time: 1:00 p.m. to 5:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute on Aging, 5601 

Fishers Lane, Rockville, MD 20892, (Virtual 

Meeting). 

Contact Person: Dario Dieguez, Ph.D., 

Scientific Review Officer, Scientific Review 

Branch, National Institutes of Health, 5601 

Fishers Lane, Rockville, MD 20814, (301) 

827–3101, dario.dieguez@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.866, Aging Research, 

National Institutes of Health, HHS) 

Dated: September 30, 2024. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–22876 Filed 10–2–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Notice of Diabetes Mellitus Interagency 

Coordinating Committee Meeting 

AGENCY: National Institutes of Health, 

HHS. 

ACTION: Notice. 

SUMMARY: The Diabetes Mellitus 

Interagency Coordinating Committee 

(DMICC) will hold a hybrid (virtual/inperson) meeting on November 12, 2024. 

The topic for this meeting will be 

‘‘Opportunities for Research Supported 

by the Special Statutory Funding 

Program for Type 1 Diabetes Research.’’ 

The meeting is open to the public. 

DATES: The meeting will be held on 

November 12, 2024, from 8:30 a.m. to 

5:00 p.m. EDT. 

ADDRESSES: This hybrid meeting will 

convene virtually via the Zoom online 

video conferencing platform or in 

person at: National Institutes of Health 

Campus, Natcher Conference Center 

(Building 45), Room E1/E2, 45 Center 

Drive, Bethesda, MD 20894. Attendance 

for the meeting will be accessible to 

members of the public who register at 

www.scgcorp.com/DMICC2024/ 

Registration by November 5, 2024. 

FOR FURTHER INFORMATION CONTACT: For 

further information concerning this 

meeting, including a draft agenda, 

which will be posted when available, 

see the DMICC website, https://

www.niddk.nih.gov/about-niddk/ 

advisory-coordinating-committees/ 

diabetes-mellitus-interagencycoordinating-committeedmicc?dkrd=lgdmn0022, or contact Dr. 

William Cefalu, Executive Secretary of 

the Diabetes Mellitus Interagency 

Coordinating Committee, National 

Institute of Diabetes and Digestive and 

Kidney Diseases, 6707 Democracy 

Boulevard, Democracy 2, Room 6037, 

Bethesda, MD 20892, telephone: 301– 

435–1011; email: dmicc@mail.nih.gov. 

SUPPLEMENTARY INFORMATION: In 

accordance with 42 U.S.C. 285c–3, the 

DMICC, chaired by the National 

Institute of Diabetes and Digestive and 

Kidney Diseases (NIDDK) and 

comprising members of the Department 

of Health and Human Services and other 

federal agencies that support diabetesrelated activities, facilitates cooperation, 

communication, and collaboration on 

diabetes among government entities. 

DMICC meetings, held several times a 

year, provide an opportunity for 

Committee members to learn about and 

discuss current and future diabetes 

programs in DMICC member 

organizations and to identify 

opportunities for collaboration. The 

November 12, 2024 DMICC meeting will 

focus on ‘‘Opportunities for Research 

Supported by the Special Statutory 

Funding Program for Type 1 Diabetes 

Research.’’ 

Any interested person may file 

written comments with the Committee 

by forwarding their statement to the 

contact person listed on this notice. The 

statement should include the name, 

address, telephone number and, when 

applicable, the business or professional 

affiliation of the interested person. 

Because of time constraints for the 

meeting, there will not be time on the 

agenda for oral comments from 

members of the public. 

Members of the public who would 

like to receive email notification about 

future DMICC meetings should register 

for the listserv available on the DMICC 

website, https://www.niddk.nih.gov/ 

about-niddk/advisory-coordinatingcommittees/diabetes-mellitusinteragency-coordinating-committeedmicc?dkrd=lgdmn0022. 

Dated: September 24, 2024. 

William T. Cefalu, 

Director, Division of Diabetes, Endocrinology, 

and Metabolic Diseases, National Institute of 

Diabetes and Digestive and Kidney Diseases, 

National Institutes of Health. 

[FR Doc. 2024–22863 Filed 10–2–24; 8:45 am] 

BILLING CODE 4140–01–P 


ddrumheller on DSK120RN23PROD with NOTICES1